Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of F. Prausnitzii on Glycemic Control - a Randomized, Double Blind, Placebo-controlled Study

NCT04938843 is registered in ClinicalTrials.gov with MetaboGen AB as lead sponsor.

NCT NCT04938843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04938843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of F. Prausnitzii on Glycemic Control - a Randomized, Double Blind, Placebo-controlled Study
Lead sponsor
MetaboGen AB
Phase
Not applicable
Overall status
Unknown status
Start date
August 16, 2021
Completion date
December 31, 2023
Enrollment
176 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impaired glucose tolerance, non-alcoholic fatty liver disease, pre diabetes